Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Kazakova

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancers|June 4, 2020
Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated MacrophagesIrina Larionova, Elena Kazakova, Marina Patysheva, et al.
Frontiers in Oncology|January 23, 2023
Macrophage scavenger receptors: Tumor support and tumor inhibitionElena Kazakova, Pavel Iamshchikov, Irina Larionova, et al.
Cancers|July 2, 2021
New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor AngiogenesisIrina Larionova, Elena Kazakova, Tatiana Gerashchenko, et al.
Chemical Biology & Drug Design|November 6, 2025
Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three-Dimensional Cancer Models PKIVladislav Lobanov, Natalia Rossomakhina, Elena Kazakova, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 15, 2023
Determination of alkaloid-inspired molecule vindeburnol in rabbit plasma by UPLC-HRMS and its application to pharmacokinetic studies and preliminary metabolite identificationAndrey Tsedilin, Lyudmila Borets, Olga Riabova, et al.
European Journal of Medicinal Chemistry|December 28, 2019
Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enterovirusesAnna Egorova, Elena Kazakova, Birgit Jahn, et al.
Antiviral Research|September 5, 2024
Dynamic features of virus protein 1 and substitutions in the 3-phenyl ring determine the potency and broad-spectrum activity of capsid-binding pyrazolo[3,4-d]pyrimidines against rhinovirusesMartina Richter, Maria Khrenova, Elena Kazakova, et al.
ACS Omega|November 29, 2023
1-Sulfonyl-3-amino-1<i>H</i>-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure-Activity RelationshipElena Kazakova, Thomas R Lane, Thane Jones, et al.
Antiviral Research|January 20, 2024
Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistanceMartina Richter, Kristin Döring, Dieter Blaas, et al.
Frontiers in Microbiology|March 25, 2025
Efficacy of dispirotripiperazine PDSTP in a golden Syrian hamster model of SARS-CoV-2 infectionGiuseppina Sanna, Olga Riabova, Elena Kazakova, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancers|June 4, 2020
Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated MacrophagesIrina Larionova, Elena Kazakova, Marina Patysheva, et al.
Frontiers in Oncology|January 23, 2023
Macrophage scavenger receptors: Tumor support and tumor inhibitionElena Kazakova, Pavel Iamshchikov, Irina Larionova, et al.
Cancers|July 2, 2021
New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor AngiogenesisIrina Larionova, Elena Kazakova, Tatiana Gerashchenko, et al.
Chemical Biology & Drug Design|November 6, 2025
Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three-Dimensional Cancer Models PKIVladislav Lobanov, Natalia Rossomakhina, Elena Kazakova, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 15, 2023
Determination of alkaloid-inspired molecule vindeburnol in rabbit plasma by UPLC-HRMS and its application to pharmacokinetic studies and preliminary metabolite identificationAndrey Tsedilin, Lyudmila Borets, Olga Riabova, et al.
European Journal of Medicinal Chemistry|December 28, 2019
Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enterovirusesAnna Egorova, Elena Kazakova, Birgit Jahn, et al.
Antiviral Research|September 5, 2024
Dynamic features of virus protein 1 and substitutions in the 3-phenyl ring determine the potency and broad-spectrum activity of capsid-binding pyrazolo[3,4-d]pyrimidines against rhinovirusesMartina Richter, Maria Khrenova, Elena Kazakova, et al.
ACS Omega|November 29, 2023
1-Sulfonyl-3-amino-1<i>H</i>-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure-Activity RelationshipElena Kazakova, Thomas R Lane, Thane Jones, et al.
Antiviral Research|January 20, 2024
Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistanceMartina Richter, Kristin Döring, Dieter Blaas, et al.
Frontiers in Microbiology|March 25, 2025
Efficacy of dispirotripiperazine PDSTP in a golden Syrian hamster model of SARS-CoV-2 infectionGiuseppina Sanna, Olga Riabova, Elena Kazakova, et al.
Pageof 3